NASHVILLE, Tenn., Feb. 15, 2022 /PRNewswire/ — Pivot Point Consulting, a Vaco Company, today announced a new LinkedIn Live series providing a forum for subject matter experts and healthcare leaders to discuss key industry topics.
The LinkedIn Live series debuts Wednesday, Feb. 16 at 1 p.m. Central with “Let’s Get Real About Virtual.” The session, Telehealth Trends: 3 Forces Impacting Telehealth Transformation, will feature Julie Edwards, Director of Virtual Care at Carle Health, and Nick Loftin, Director of Virtual Care at Pivot Point and will be moderated by Laura Kreofsky, Pivot Point’s Vice President of Strategy.
The conversation will focus on:
“Virtual care is evolving rapidly so it’s important to have dynamic forums, like LinkedIn Live, for healthcare providers to engage in real time,” Loftin said. “Our goal is to share what we’re seeing in the industry and provide practical insights on how to successfully pivot in a rapidly changing healthcare market.”
Beyond telehealth, Pivot Point Consulting’s new LinkedIn Live series will cover industry topics including Managed Services, Mergers & Acquisitions, Data & Analytics, as well as EHR and ERP implementation and optimization best practices.
Follow Pivot Point Consulting on LinkedIn to be the first to know when future LinkedIn Live events are announced.
About Pivot Point Consulting
Pivot Point Consulting enables healthcare organizations to realize the most value from their technology and resources through EHR, ERP, Strategy, Virtual Care, Data & Analytics, Cybersecurity, Service Desk, Application Support and Revenue Cycle Management services. Our experts deliver consulting, managed services and talent solutions to providers, payers, life sciences and technology organizations.
For more information, visit us at pivotpointconsulting.com.
Media Contact:
Kim Warth, Amendola Communications, kwarth@acmarketingpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/pivot-point-consulting-launches-linkedin-live-series–kicking-off-with-telehealth-301482206.html
SOURCE Pivot Point Consulting
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…